“…78 Use of intravitreal of tPA and sulfur hexafluoride in the management of Terson syndrome has been reported in 1 case. 79 The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection. 79 Nd:YAG Laser Nd:YAG laser can disrupt and drain preretinal hemorrhage in both children and adults with Terson syndrome.…”
“…79 The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection. 79 Nd:YAG Laser Nd:YAG laser can disrupt and drain preretinal hemorrhage in both children and adults with Terson syndrome. [80][81][82] A laser beam is used to break the posterior hyaloid, allowing blood to enter the vitreous.…”
“…Use of intravitreal of tPA and sulfur hexafluoride in the management of Terson syndrome has been reported in 1 case 79 . The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection 79 …”
Section: Managementmentioning
confidence: 95%
“…Subretinal hemorrhages that develop as a consequence of Terson syndrome can be managed with subretinal tPA injections 78 . Use of intravitreal of tPA and sulfur hexafluoride in the management of Terson syndrome has been reported in 1 case 79 . The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection 79 …”
“…78 Use of intravitreal of tPA and sulfur hexafluoride in the management of Terson syndrome has been reported in 1 case. 79 The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection. 79 Nd:YAG Laser Nd:YAG laser can disrupt and drain preretinal hemorrhage in both children and adults with Terson syndrome.…”
“…79 The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection. 79 Nd:YAG Laser Nd:YAG laser can disrupt and drain preretinal hemorrhage in both children and adults with Terson syndrome. [80][81][82] A laser beam is used to break the posterior hyaloid, allowing blood to enter the vitreous.…”
“…Use of intravitreal of tPA and sulfur hexafluoride in the management of Terson syndrome has been reported in 1 case 79 . The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection 79 …”
Section: Managementmentioning
confidence: 95%
“…Subretinal hemorrhages that develop as a consequence of Terson syndrome can be managed with subretinal tPA injections 78 . Use of intravitreal of tPA and sulfur hexafluoride in the management of Terson syndrome has been reported in 1 case 79 . The authors observed resorption of subretinal hemorrhage and improvement in visual acuity 1 week after the injection 79 …”
Tissue plasminogen activator and C3F8, combined with intravitreal ranibizumab or photodynamic therapy, may result in anatomical clearance of submacular hemorrhage and improved visual acuity, in a condition with an otherwise poor visual prognosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.